GAD1 is a biomarker for benign and malignant prostatic tissue

References

• Canney PA, Moore M, Wilkinson PM, James RD. Ovarian cancer antigen CA125: a prospective clinical assessment of its role as a tumour marker. Br J Cancer 1984;50:765–9.
   PubMed Web of Science ®Google Scholar
• McShane LM, Altman DG, Sauerbrei W, Taube SE, Gion M, Clark GM. REporting recommendations for tumor MARKer prognostic studies (REMARK). Breast Cancer Res Treat 2006;100:229–35.
   PubMed Web of Science ®Google Scholar
• Gronberg H. Prostate cancer epidemiology. Lancet 2003;361:859–64.
   PubMed Web of Science ®Google Scholar
• Adolfsson J, Garmo H, Varenhorst E, Ahlgren G, Ahlstrand C, Andren O, Clinical characteristics and primary treatment of prostate cancer in Sweden between 1996 and 2005. Scand J Urol Nephrol 2007;41:456–77.
   PubMed Web of Science ®Google Scholar
• Candas B, Cusan L, Gomez JL, Diamond P, Suburu RE, Levesque J, Evaluation of prostatic specific antigen and digital rectal examination as screening tests for prostate cancer. Prostate 2000;45:19–35.
   PubMed Web of Science ®Google Scholar
• Catalona WJ, Smith DS, Ratliff TL, Basler JW. Detection of organ-confined prostate cancer is increased through prostate-specific antigen-based screening. JAMA 1993;270:948–54.
   PubMed Web of Science ®Google Scholar
• Chuang AY, DeMarzo AM, Veltri RW, Sharma RB, Bieberich CJ, Epstein JI. Immunohistochemical differentiation of high-grade prostate carcinoma from urothelial carcinoma. Am J Surg Pathol 2007;31:1246–55.
   PubMed Web of Science ®Google Scholar
• Sheridan T, Herawi M, Epstein JI, Illei PB. The role of P501S and PSA in the diagnosis of metastatic adenocarcinoma of the prostate. Am J Surg Pathol 2007;31:1351–5.
   PubMed Web of Science ®Google Scholar
• Sardana G, Dowell B, Diamandis EP. Emerging biomarkers for the diagnosis and prognosis of prostate cancer. Clin Chem 2008;54:1951–60.
   PubMed Web of Science ®Google Scholar
• Bu DF, Erlander MG, Hitz BC, Tillakaratne NJ, Kaufman DL, Wagner-McPherson CB, Two human glutamate decarboxylases, 65-kDa GAD and 67-kDa GAD, are each encoded by a single gene. Proc Natl Acad Sci U S A 1992;89:2115–19.
   PubMed Web of Science ®Google Scholar
• Chessler SD, Lernmark A. Alternative splicing of GAD67 results in the synthesis of a third form of glutamic-acid decarboxylase in human islets and other non-neural tissues. J Biol Chem 2000;275:5188–92.
   PubMed Web of Science ®Google Scholar
• Sobin LH, Hjermstad BM, Sesterhenn IA, Helwig EB. Prostatic acid phosphatase activity in carcinoid tumors. Cancer 1986;58:136–8.
   PubMed Web of Science ®Google Scholar
• Epstein JI, Kuhajda FP, Lieberman PH. Prostate-specific acid phosphatase immunoreactivity in adenocarcinomas of the urinary bladder. Hum Pathol 1986;17:939–42.
   PubMed Web of Science ®Google Scholar
• Quintero IB, Araujo CL, Pulkka AE, Wirkkala RS, Herrala AM, Eskelinen EL, Prostatic acid phosphatase is not a prostate specific target. Cancer Res 2007;67:6549–54.
   PubMed Web of Science ®Google Scholar
• Jonmarker S, Glaessgen A, Culp WD, Pisa P, Lewensohn R, Ekman P, Expression of PDX-1 in prostate cancer, prostatic intraepithelial neoplasia and benign prostatic tissue. APMIS 2008;116:491–8.
   PubMed Web of Science ®Google Scholar
• Paavilainen L, Wernerus H, Nilsson P, Uhlen M, Hober S, Wester K, Evaluation of monospecific antibodies: a comparison study with commercial analogs using immunohistochemistry on tissue microarrays. Appl Immunohistochem Mol Morphol 2008;16:493–502.
   PubMedGoogle Scholar
• Nilsson P, Paavilainen L, Larsson K, Odling J, Sundberg M, Andersson AC, Towards a human proteome atlas: high-throughput generation of mono-specific antibodies for tissue profiling. Proteomics 2005;5:4327–37.
   PubMed Web of Science ®Google Scholar
• Wright GL Jr, Grob BM, Haley C, Grossman K, Newhall K, Petrylak D, Upregulation of prostate-specific membrane antigen after androgen-deprivation therapy. Urology 1996;48:326–34.
   PubMed Web of Science ®Google Scholar
• Varma M, Jasani B. Diagnostic utility of immunohistochemistry in morphologically difficult prostate cancer: review of current literature. Histopathology 2005;47:1–16.
   PubMed Web of Science ®Google Scholar
• Chen JC, Ho CL, Tsai HW, Tzai TS, Liu HS, Chow NH, Immunohistochemical detection of prostate-specific antigen expression in primary urothelial carcinoma of the urinary bladder. Anticancer Res 2008;28:4149–54.
   PubMed Web of Science ®Google Scholar
• Goldstein NS. Immunophenotypic characterization of 225 prostate adenocarcinomas with intermediate or high Gleason scores. Am J Clin Pathol 2002;117:471–7.
   PubMed Web of Science ®Google Scholar
• Bostwick DG, Pacelli A, Blute M, Roche P, Murphy GP. Prostate specific membrane antigen expression in prostatic intraepithelial neoplasia and adenocarcinoma: a study of 184 cases. Cancer 1998;82:2256–61.
   PubMed Web of Science ®Google Scholar
• Horoszewicz JS, Kawinski E, Murphy GP. Monoclonal antibodies to a new antigenic marker in epithelial prostatic cells and serum of prostatic cancer patients. Anticancer Res 1987;7:927–35.
   PubMed Web of Science ®Google Scholar
• Rajasekaran AK, Anilkumar G, Christiansen JJ. Is prostate-specific membrane antigen a multifunctional protein? Am J Physiol Cell Physiol 2005;288:C975–81.
   PubMed Web of Science ®Google Scholar
• Marchal C, Redondo M, Padilla M, Caballero J, Rodrigo I, Garcia J, Expression of prostate specific membrane antigen (PSMA) in prostatic adenocarcinoma and prostatic intraepithelial neoplasia. Histol Histopathol 2004;19:715–18.
   PubMed Web of Science ®Google Scholar
• Lapidus RG, Tiffany CW, Isaacs JT, Slusher BS. Prostate-specific membrane antigen (PSMA) enzyme activity is elevated in prostate cancer cells. Prostate 2000;45:350–4.
   PubMed Web of Science ®Google Scholar
• Ross JS, Sheehan CE, Fisher HA, Kaufman RP Jr, Kaur P, Gray K, Correlation of primary tumor prostate-specific membrane antigen expression with disease recurrence in prostate cancer. Clin Cancer Res 2003;9:6357–62.
   PubMed Web of Science ®Google Scholar
• Sweat SD, Pacelli A, Murphy GP, Bostwick DG. Prostate-specific membrane antigen expression is greatest in prostate adenocarcinoma and lymph node metastases. Urology 1998;52:637–40.
   PubMed Web of Science ®Google Scholar
• Chang SS, Reuter VE, Heston WD, Gaudin PB. Metastatic renal cell carcinoma neovasculature expresses prostate-specific membrane antigen. Urology 2001;57:801–5.
   PubMed Web of Science ®Google Scholar
• Kinoshita Y, Kuratsukuri K, Landas S, Imaida K, Rovito PM Jr, Wang CY, Expression of prostate-specific membrane antigen in normal and malignant human tissues. World J Surg 2006;30:628–36.
   PubMed Web of Science ®Google Scholar
• Lane Z, Hansel DE, Epstein JI. Immunohistochemical expression of prostatic antigens in adenocarcinoma and villous adenoma of the urinary bladder. Am J Surg Pathol 2008;32:1322–6.
   PubMed Web of Science ®Google Scholar
• Akbarian S, Huang HS. Molecular and cellular mechanisms of altered GAD1/GAD67 expression in schizophrenia and related disorders. Brain Res Rev 2006;52:293–304.
   PubMed Web of Science ®Google Scholar
• Yamashita K, Cram DS, Harrison LC. Molecular cloning of full-length glutamic acid decarboxylase 67 from human pancreas and islets. Biochem Biophys Res Commun 1993;192:1347–52.
   PubMed Web of Science ®Google Scholar
• Kaufman DL, Erlander MG, Clare-Salzler M, Atkinson MA, Maclaren NK, Tobin AJ. Autoimmunity to two forms of glutamate decarboxylase in insulin-dependent diabetes mellitus. J Clin Invest 1992;89:283–92.
   PubMed Web of Science ®Google Scholar
• Bjork E, Velloso LA, Kampe O, Karlsson FA. GAD autoantibodies in IDDM, stiff-man syndrome, and autoimmune polyendocrine syndrome type I recognize different epitopes. Diabetes 1994;43:161–5.
   PubMed Web of Science ®Google Scholar
• Powers AC, Bavik K, Tremble J, Daw K, Scherbaum WA, Banga JP. Comparative analysis of epitope recognition of glutamic acid decarboxylase (GAD) by autoantibodies from different autoimmune disorders. Clin Exp Immunol 1999;118:349–56.
   PubMed Web of Science ®Google Scholar
• Asada H, Kawamura Y, Maruyama K, Kume H, Ding RG, Kanbara N, Cleft palate and decreased brain gamma-aminobutyric acid in mice lacking the 67-kDa isoform of glutamic acid decarboxylase. Proc Natl Acad Sci U S A 1997;94:6496–9.
   PubMed Web of Science ®Google Scholar
• Cheung PK, Woolcock B, Adomat H, Sutcliffe M, Bainbridge TC, Jones EC, Protein profiling of microdissected prostate tissue links growth differentiation factor 15 to prostate carcinogenesis. Cancer Res 2004;64:5929–33.
   PubMed Web of Science ®Google Scholar